Royal Bank of Canada’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-700
| Closed | -$34K | – | 6586 |
|
|
2020
Q1 | $34K | Sell |
700
-59,262
| -99% | -$2.88M | ﹤0.01% | 4832 |
|
|
2019
Q4 | $2.81M | Buy |
59,962
+59,262
| +8,466% | +$2.78M | ﹤0.01% | 2165 |
|
|
2019
Q3 | $17K | Sell |
700
-5
| -0.7% | -$121 | ﹤0.01% | 4968 |
|
|
2019
Q2 | $21K | Buy |
705
+5
| +0.7% | +$149 | ﹤0.01% | 4943 |
|
|
2019
Q1 | $16K | Sell |
700
-3
| -0.4% | -$69 | ﹤0.01% | 4968 |
|
|
2018
Q4 | $13K | Sell |
703
-159
| -18% | -$2.94K | ﹤0.01% | 5022 |
|
|
2018
Q3 | $16K | Buy |
862
+846
| +5,288% | +$15.7K | ﹤0.01% | 5191 |
|
|
2018
Q2 | $0 | Buy |
16
+9
| +129% | – | ﹤0.01% | 6202 |
|
|
2018
Q1 | $0 | Buy |
+7
| New | – | ﹤0.01% | 6178 |
|
|
2017
Q4 | – | Sell |
-1,069
| Closed | -$16K | – | 6232 |
|
|
2017
Q3 | $16K | Buy |
+1,069
| New | +$16K | ﹤0.01% | 5335 |
|
|
2017
Q2 | – | Sell |
-222
| Closed | -$5K | – | 6076 |
|
|
2017
Q1 | $5K | Sell |
222
-273
| -55% | -$6.15K | ﹤0.01% | 5550 |
|
|
2016
Q4 | $8K | Buy |
+495
| New | +$8K | ﹤0.01% | 5410 |
|